Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 17/20 | 0.40 |
| ▸ | THRA | P10827 | 17/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | UGT1A1 | P22309 | 1/20 | 0.36 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22632552 | 1.00 | THRB (0.40) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL30820597 | 0.92 | THRB (0.39) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL13116309 | 0.92 | THRB (0.39) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL23022535 | 0.85 | THRB (0.35) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL24032733 | 0.85 | THRB (0.34) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL23828939 | 0.82 | MAPT (0.34) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL38650551 | 0.80 | THRB (0.35) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL21749505 | 0.80 | THRB (0.35) | THRBTHRACYP2C9UGT1A1ABCG2 | |
| SCHEMBL31054377 | 0.79 | THRA (0.38) | THRBTHRALMNA | |
| SCHEMBL31054367 | 0.79 | THRA (0.36) | THRBTHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036699-A | THR-beta modulators and methods of use thereof | 阿利戈斯治疗公司 | 2026-05-15 | — | — | CN | disclosed |